Publication:
Cost of rotavirus diarrhea for programmatic evaluation of vaccination in Vietnam

dc.contributor.authorArthorn Riewpaiboonen_US
dc.contributor.authorSunheang Shinen_US
dc.contributor.authorThi Phuong Mai Leen_US
dc.contributor.authorDinh Thiem Vuen_US
dc.contributor.authorThi Hien Anh Nguyenen_US
dc.contributor.authorNeal Alexanderen_US
dc.contributor.authorDuc Anh Dangen_US
dc.contributor.authorRotavirus Economic Study Groupen_US
dc.contributor.otherMahidol University. Faculty of Pharmacyen_US
dc.date.accessioned2017-10-10T04:28:19Z
dc.date.available2017-10-10T04:28:19Z
dc.date.created2017-10-10
dc.date.issued2016
dc.description.abstractBackground: Rotavirus is the most common etiology of diarrhea-associated hospitalizations and clinic visits in Vietnamese children < 5 years old. To estimate the economic burden of rotavirus-associated formal healthcare encounters, an economic study was conducted. Methods: A cost-of-illness study was performed from a societal perspective. Data were collected from children below the age of five years who presented to a clinic or hospital with symptoms of acute gastroenteritis (AGE). Patient-specific information on resource use and cost was obtained through caregiver interviews and medical chart review. Costs are presented in 2014 US dollar ($). Results: A total of 557 children with symptoms of AGE were enrolled from March through June 2009, with mean age of 16.5 months. Of the 340 outpatients and 217 admitted patients enrolled, 41 % tested rotavirus positive. It was found that, from a societal perspective, the mean total cost of AGE was $175. Costs of patients with and without rotavirus were $217 and $158, respectively. From multiple regression analysis, it was found that rotavirus infection, patient age and receiving oral rehydration solution before visiting health facility had significant effect on the costs. Conclusions: This study clearly demonstrated substantial economic burden of AGE including rotavirus disease. They were significantly greater than the previously reported cost estimates in Vietnam. These updated costs of illness result in more favorable vaccine cost-effectiveness than in previous economic evaluations.en_US
dc.identifier.citationBMC Public Health. vol. 16, (2016), 777en_US
dc.identifier.doi10.1186/s12889-016-3458-2
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/2842
dc.language.isoengen_US
dc.rightsMahidol Universityen_US
dc.rights.holderBioMed Centralen_US
dc.subjectRotavirus burdenen_US
dc.subjectAcute gastroenteritisen_US
dc.subjectCost of illnessen_US
dc.subjectVietnamen_US
dc.titleCost of rotavirus diarrhea for programmatic evaluation of vaccination in Vietnamen_US
dc.typeResearch Articleen_US
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
py-ar-arthorn-2016.pdf
Size:
440.14 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections